Recent antibody targeting technologies - A survey of the patent literature

Research output: Contribution to journalEditorialpeer-review

1 Citation (SciVal)


The widespread application of antibody therapies has recently become a promising reality. This has come about because of advances in our understanding of the Chemistry and Biology of antibodies, our ability to engineer or create human versions of antibodies directed at specific targets, and our ability to generate large, highly purified quantities of these antibodies for clinical use. With the potential for an increased number of specific target site coming from information garnered from the sequence of the human genome, it seems highly likely that the best is yet to come for antibody-directed drug targeting therapies.

Original languageEnglish
Pages (from-to)141-148
Number of pages8
JournalJournal of Drug Targeting
Issue number3
Publication statusPublished - 31 Dec 1998

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Recent antibody targeting technologies - A survey of the patent literature'. Together they form a unique fingerprint.

Cite this